Cover of DeepMind's AlphaGenome Maps Every DNA Mutation — Sep 14, 2026

DeepMind's AlphaGenome Maps Every DNA Mutation — Sep 14, 2026

DeepMind's AlphaGenome Maps Every DNA Mutation — Sep 14, 2026

Listen for free

View show details

Season's Savings | 0.99 €/month for 3 months

5.99 €/month thereafter - terms apply. Cancel monthly.

Google just mapped every possible way a single DNA letter can go wrong.

Run time: 7:23

In today's episode:

  1. DeepMind maps all 9 billion possible DNA mutations
  2. UK proposes 44 new rules for medical AI
  3. Rural AI push meets skepticism from actual providers
  4. OpenEvidence restricts its best model over dual-use risk
  5. AI spots collapsed lungs in newborns, 87.6% sensitivity
  6. AI-measured organ volume linked to kidney cancer survival
  7. Claude Fable 5.1 and Mythos 5.1 go live
  8. GPT-6 Astra rated "critical" cyber risk by OpenAI

TL;DR:

  • DeepMind released the AlphaGenome Atlas, a free public database predicting the biological effect of all 9 billion possible single-letter DNA changes — built with Broad, Harvard, and Boston Children's, with DeepMind's own caveat that it is not clinically validated.
  • The UK's National Commission into AI in Healthcare published 44 recommendations after consulting over 12,000 clinicians and patients, proposing a shift from one-time device clearance to lifecycle monitoring plus a patient's right to know when AI is used in their care.
  • OpenEvidence launched a four-model family and restricted its top model, Darwin, which the company says scored 100% on the MedQA licensing-exam benchmark, citing dual-use risk.

Sources cited:

  • Google DeepMind
  • GOV.UK
  • OpenEvidence
  • STAT News
  • Pediatric Radiology
  • Annals of Medicine
  • Anthropic
  • OpenAI

Subscribe: YouTube

medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

adbl_web_anon_alc_button_suppression_t1
No reviews yet